Solid Biosciences Inc. Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 13.62M8.09M-0.44M-0.34M
Gross Profit 13.62M8.09M-0.44M-0.34M
Operating items
Research & Development 20.12M39.91M57.97M94.74M64.88M58.74M78.42M76.56M96.43M
Selling, General & Administrative 5.46M14.95M17.72M24.58M21.58M27.14M28.95M27.75M33.30M
Restructuring Costs 1.94M7.18M-0.06M
Operating Expenses 25.58M54.86M75.69M119.32M88.41M85.87M114.55M104.25M129.73M
Operating Income -25.58M-54.86M-75.69M-119.32M-88.41M-72.25M-106.45M-104.25M-129.73M
EBIT -25.58M-54.86M-75.69M-119.32M-88.41M-72.25M-106.45M-104.25M-129.73M
Non-operating items
Non Operating Investment Income -4.75M
Interest & Investment Income 0.37M0.22M0.62M1.58M0.12M0.06M2.62M7.58M9.47M
Other Non Operating Income 0.27M1.00M0.27M0.52M0.00M0.00M-0.38M1.09M0.65M
Non Operating Income 1.80M1.68M0.89M2.10M0.12M0.07M20.47M8.24M5.03M
Net income details
EBT -25.21M-54.64M-75.07M-117.74M-88.29M-72.19M-103.84M-97.11M-120.60M
Profit After Tax -23.77M-53.18M-74.80M-117.22M-88.29M-72.19M-85.98M-96.02M-124.70M
Income from Non-Controlling Interests -2.23M-1.06M
Income from Continuing Operations -25.21M-54.64M-75.07M-117.74M-88.29M-72.19M-103.84M-97.11M-120.60M
Consolidated Net Income -25.21M-54.64M-75.07M-117.74M-88.29M-72.19M-103.84M-97.11M-120.60M
Income towards Parent Company -25.21M-54.64M-75.07M-117.74M-88.29M-72.19M-103.84M-97.11M-120.60M
Preferred Dividend Payments -4.31M0.96M
Net Income towards Common Stockholders -17.23M-39.32M-74.80M-117.22M-88.29M-72.19M-103.84M-97.11M-120.60M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 2.22M2.36M3.07M4.03M7.35M7.53M20.18M39.95M
Shares Outstanding (Diluted Average) 3.46M7.12M8.51M19.88M
EBITDA -25.58M-54.86M-75.69M-119.32M-88.41M-72.25M-106.45M-104.25M-129.73M